| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/03/2003 | WO2001098512A3 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 01/03/2003 | WO2001098470A3 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2003 | WO2001083819A9 Methods for designing exogenous regulatory molecules |
| 01/03/2003 | WO2001081632A9 Methods for monitoring the expression of alternatively spliced genes |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001077382A3 Genetic factor affecting cytokine expression |
| 01/03/2003 | WO2001075452A9 Detection of nerve damage using marker scip |
| 01/03/2003 | WO2001075154A3 Novel method for the parallel sequencing of a nucleic acid mixture on a surface |
| 01/03/2003 | WO2001068910A3 Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner |
| 01/03/2003 | WO2001066555A9 Methods for assay and detection on a microarray |
| 01/03/2003 | WO2001062959A3 Endometriosis-related markers and uses thereof |
| 01/03/2003 | WO2001057272A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 01/03/2003 | WO2001057251A3 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 01/03/2003 | CA2677781A1 Nitrilases |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451864A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | CA2451753A1 Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451637A1 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | CA2451498A1 Methods and oligonucleotides for the detection of salmonella sp., e. coli o157:h7, and listeria monocytogenes |
| 01/03/2003 | CA2451486A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | CA2451437A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | CA2451380A1 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451328A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | CA2451323A1 A nucleic acid-based method for tree phenotype prediction: dna markers for fibre coarseness, microfibril angle, pulp strength and yield, lignin content, pitch propensity and calcium accumulation determinants |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451247A1 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | CA2451222A1 Configurable dynamic three dimensional array |
| 01/03/2003 | CA2451201A1 Microfabricated two-pin liquid sample dispensing system |
| 01/03/2003 | CA2451161A1 Method for high through put screening using a small scale mill or microfluidics |
| 01/03/2003 | CA2451035A1 Microfabricated separation device employing a virtual wall for interfacing fluids |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450792A1 Homoaconitase as a target for fungicides |
| 01/03/2003 | CA2450580A1 Method for the determination of telomere length |
| 01/03/2003 | CA2450577A1 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 01/03/2003 | CA2450479A1 Method for detecting diseases caused by chromosomal imbalances |
| 01/03/2003 | CA2449990A1 Type 1 diabetes diagnostics and therapeutics |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004306 Fluorescent protein |
| 01/02/2003 | US20030004120 Apoptosis; antitumor, anticancer agents |
| 01/02/2003 | US20030004117 Methods for inhibiting angiogenesis |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004093 Method for identifying compounds for inhibition of neoplastic lesions |
| 01/02/2003 | US20030003609 Ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 01/02/2003 | US20030003598 Method, system and computer program product for measuring unit activity of an enzyme |
| 01/02/2003 | US20030003588 Method for kidney disease detection by protein profiling |
| 01/02/2003 | US20030003578 Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicity of a sample and the kinetics of the genotoxicity |
| 01/02/2003 | US20030003559 Nucleotide sequences coding polypeptide for use in the treatment of diabetes, kidney, and liver disorders |
| 01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 01/02/2003 | US20030003549 Detection of human hepatitis b virus surface antigen mutants by specific amplification and its application on gene chip |
| 01/02/2003 | US20030003546 Treating degenerative cartilaginous disorders and other inflammatory diseases |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003543 Methods and applications for efficient genetic suppressor elements |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003540 Coding and classification of microorganisms; obtain sample, filter through membrane, incubate microorganism, incubate with peptide nucleic acid probe, detect signal |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders |
| 01/02/2003 | US20030003527 Kits for use in the detection of preferential microorghanism |
| 01/02/2003 | US20030003526 Compound for use in the measurement of gene expression |
| 01/02/2003 | US20030003524 Analytical element and measuring device and substrate quantification method using the same |
| 01/02/2003 | US20030003523 Conductometric detection process |
| 01/02/2003 | US20030003521 Marker for inflammatory conditions |
| 01/02/2003 | US20030003519 Compositions and methods for the discovery and selection of biological information |
| 01/02/2003 | US20030003510 Biophotonic sensors and methods of use thereof |
| 01/02/2003 | US20030003507 Compositions and methods for the diagnosis and treatment of tumor |
| 01/02/2003 | US20030003500 Apparatus for screening and detecting preferential particles in sample |
| 01/02/2003 | US20030003498 Analyzing preferential nucleotide sequences; obtain sample, incubate with primer, amplify, apply an electric field, detect and recover nucleotide sequences products |
| 01/02/2003 | US20030003496 Novel compositions and methods for array-based nucleic acid hybridization |
| 01/02/2003 | US20030003495 Systems, tools and methods of assaying biological materials using spatially-addressable arrays |
| 01/02/2003 | US20030003493 Apparatus for use in measuring and analyzing radiation emission from samples |
| 01/02/2003 | US20030003490 Mapping preferential nucleic acid position in biopolymer; obtain nucleotide sequence sample, incubate with probe, amplify, determine position of preferential nucleotide sequences |
| 01/02/2003 | US20030003486 Oligonucleotide for use as signaling tool in genetic analysis |
| 01/02/2003 | US20030003484 Universal microarray system |
| 01/02/2003 | US20030003483 Amplifiable probe |
| 01/02/2003 | US20030003481 Detection of nucletide sequence polymerase inhibitors; obtain nucleotide sequences, incubate wih inhibitors, detect reduction in enzyme activity, reduction enzyme activity indicates inhibitor |
| 01/02/2003 | US20030003479 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
| 01/02/2003 | US20030003478 Identifying and characterizing genes |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003475 Arrays for detecting nucleic acids |
| 01/02/2003 | US20030003473 Electrodes linked via conductive oligomers to nucleic acids |
| 01/02/2003 | US20030003472 Detection of genetic aberration in sample; obtain nucleotide sequences, incubate with oligonucleotides, detect aberration in hybridization, presence of aberration indicates variablity in nucleotide sequences |
| 01/02/2003 | US20030003470 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 01/02/2003 | US20030003468 Markers for disease susceptibility and targets for therapy |
| 01/02/2003 | US20030003467 Methods for diagnosing and treating pediatric neoplasms |
| 01/02/2003 | US20030003464 Detection of preferential particles in sample; obtain sample, incubate with binding agent, detect bound particles |
| 01/02/2003 | US20030003463 Methods and devices for measuring differential gene expression |